会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Method and apparatus for determining atrial lead dislocation
    • 用于确定心房铅脱位的方法和装置
    • US06195584B1
    • 2001-02-27
    • US09303279
    • 1999-04-30
    • Michael R. S. HillRahul MehraMichael F. HessRaylene Pitschneider
    • Michael R. S. HillRahul MehraMichael F. HessRaylene Pitschneider
    • A61N137
    • A61N1/371A61N2001/083
    • A method and apparatus for determining the occurrence of a mis-location of an atrial electrode in a cardiac stimulation device having an atrial pulse generator coupled with the atrial electrode and a ventricular sense amplifier coupled to a ventricular electrode. The device paces the atrium in a first pacing mode employing atrial pacing pulses at a first energy level and in a test mode employs higher energy atrial pacing pulses. In the test mode the device measures PR intervals between atrial pacing pulses following sensed ventricular depolarizations and determines that the atrial electrode is mis-located responsive to occurrence of a threshold number of short PR intervals or that the atrial electrode is appropriately located responsive to occurrence of a threshold number of long PR intervals. Operation of the device in the test mode may be pre-conditioned on an absence of atrial tachyarrhythmia.
    • 一种用于确定在具有与心房电极耦合的心房脉冲发生器和耦合到心室电极的心室感应放大器的心脏刺激装置中心房电极错位的发生的方法和装置。 该装置以第一起搏模式采用心房起搏脉冲在第一能级进行起搏,并且在测试模式中采用更高能量的心房起搏脉冲。 在测试模式中,该装置测量感测到的心室去极化之后的心房起搏脉冲之间的PR间隔,并且确定心房电极响应于出现阈值数量的短PR间期而错位,或者心房电极适当地位于响应于 长PR间隔的阈值数。 在测试模式下的装置的操作可以在没有心房快速性心律失常的情况下进行预处理。
    • 3. 发明授权
    • Apparatus for treating atrial tachyarrhythmias with synchronized shocks
    • 用同步冲击治疗房性快速性心律失常的装置
    • US6091988A
    • 2000-07-18
    • US70690
    • 1998-04-30
    • Eduardo N. WarmanMichael R. S. HillDavid K. L. PetersonRahul MehraLuc R. Mongeon
    • Eduardo N. WarmanMichael R. S. HillDavid K. L. PetersonRahul MehraLuc R. Mongeon
    • A61N1/362A61N1/39
    • A61N1/3956A61N1/3622A61N1/3987
    • An implantable anti-tachyarrhythmia device which delivers atrial cardioversion or defibrillation pulses heart in response to detection of atrial tachyarrhythmias. The pulses are synchronized to atrial and ventricular events in such a fashion as to assure they occur outside of the vulnerable periods associated with both chambers. The device is provided with a pulse synchronizer which defines a first synchronization interval initiated following a sensed atrial event and a second synchronization interval initiated responsive to a sensed ventricular event and a pulse triggerer which triggers delivery of a cardioversion or defibrillation pulse responsive to the first and second synchronization intervals simultaneously being underway. In particular, the pulse triggerer may be responsive to initiation of the first synchronization interval during the second synchronization interval. In addition, the synchronizer may also define minimum time intervals following ventricular events and the triggerer may additionally be responsive to expiration of a defined minimum time interval following a ventricular event preceding the sensed ventricular event which initiated the second synchronization interval currently underway.
    • 一种可植入的抗快速性心律失常装置,其响应于心房快速性心律失常的检测而传送心房心脏复律或除颤脉冲心脏。 这些脉冲以这样的方式与心房和心室事件同步,以确保它们发生在与两个腔室相关联的脆弱周期之外。 该装置设置有脉冲同步器,该脉冲同步器限定在感测的心房事件之后启动的第一同步间隔和响应于感测到的心室事件而发起的第二同步间隔和脉冲触发器,其响应于第一和第二同步间隔触发心脏复律或除颤脉冲的传递 第二同步间隔同时进行。 特别地,脉冲触发器可以响应于在第二同步间隔期间启动第一同步间隔。 此外,同步器还可以定义心室事件之后的最小时间间隔,并且触发器可以另外响应于起始于当前正在进行的第二同步区间的感测的心室事件之前的心室事件之后的限定的最小时间间隔的到期。
    • 4. 发明授权
    • Cardioversion energy reduction system
    • 心律转换能量减少系统
    • US5836976A
    • 1998-11-17
    • US846747
    • 1997-04-30
    • Xiaoyi MinLi WangRahul MehraPaul J. DeGrootWalter H. OlsonLuc R. MongeonMichael R. S. Hill
    • Xiaoyi MinLi WangRahul MehraPaul J. DeGrootWalter H. OlsonLuc R. MongeonMichael R. S. Hill
    • A61N1/39
    • A61N1/3956A61N1/3925A61N1/3987
    • In an implantable pacemaker/cardioverter/defibrillator, a system for correlating the delivery of a cardioversion therapy to an optimum point or phase of the respiratory cycle of the patient to effect delivery of the therapy when the impedance between the cardioversion electrodes is minimized. In a first application for use with cardioversion electrodes located substantially in contact with the heart chamber, the optimum point or phase is at the end of inspiration. In a second application for use with at least one cardioversion electrode located remotely from the heart chamber, the optimum point or phase is at end expiration or beginning of inspiration. The cardioversion therapy is delivered in synchrony with a ventricular sense event, if present. If the optimum point or phase of the respiratory cycle cannot be determined during a therapy time, a pre-shock may be delivered to elicit a respiration cycle through a stimulated contraction of the diaphragm.
    • 在植入式心脏起搏器/心律转复除颤器中,用于将心脏复律治疗的输送与患者呼吸周期的最佳点或阶段相关联的系统,以在心脏复律电极之间的阻抗最小化时实现治疗的传递。 在与基本上与心脏腔室接触的心脏复律电极一起使用的第一个应用中,最佳点或阶段在吸气结束时。 在与远离心脏室的位置的至少一个心脏复律电极一起使用的第二个应用中,最佳点或阶段是结束期满或开始吸气。 复发疗法与心室感觉事件(如果存在)同步传递。 如果在治疗时间内不能确定呼吸周期的最佳点或相位,则可以传送预休克以通过振膜的刺激收缩引起呼吸循环。